MARTHA DEMSKI - 07 Jun 2021 Form 4 Insider Report for Adamas Pharmaceuticals Inc (ADMS)

Role
Director
Signature
/s/ Christopher B. Prentiss, Attorney-in-fact
Issuer symbol
ADMS
Transactions as of
07 Jun 2021
Transactions value $
-$10,340
Form type
4
Filing time
08 Jun 2021, 17:32:33 UTC
Previous filing
04 Jun 2021
Next filing
25 Jun 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ADMS Common Stock Sale -$10,340 -2,000 -20% $5.17 8,000 07 Jun 2021 Direct F1
holding ADMS Common Stock 13,000 07 Jun 2021 Martha J. Demski U/D/T 10/1/1994, Martha J. Demski Trustee
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This sale was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person and was effected to cover tax obligations in connection with the vesting of the reporting person's director restricted stock awards.